Chinese Atherosclerosis Risk Evaluation- Phase II
NCT02017756 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2013-12-23
Summary
Stroke is the first and the fourth leading cause of death in the United States and China, respectively. Disruption of cerebrovascular vulnerable atherosclerotic plaque is the major etiology of ischemic stroke. Therefore, early detection and treatment of vulnerable plaques occurring at the feeding arteries to brain (cerebral arteries) will be helpful for prevention of stroke.
Atherosclerosis is a systemic disease that usually affects multiple vascular beds. Previous studies have shown that these high risk lesions in different segments of cerebral arteries (intracranial and extracranial arteries) might be racially specific. It is reported that, in stroke patients, intracranial vulnerable plaques are prevalent in Asian populations whereas atherosclerosis more frequently involves extracranial carotid arteries in American subjects. However, these findings are based on angiographic imaging approaches via measuring arterial luminal stenosis. Because the atherosclerotic plaque often appears as outward expansion, namely positive remodeling during progression, measuring luminal stenosis will underestimate the disease severity. Hence, directly viewing the plaque in the vessel wall is strongly suggested in order to objectively evaluate the cerebrovascular vulnerable plaque.
High resolution, black-blood magnetic resonance (MR) imaging has been widely used to accurately characterize carotid vulnerable plaque in the last two decades. The aim of using MR black-blood techniques is to suppress the blood signal (black) to enhance the signal contrast between the vessel wall and blood in the arterial lumen. Excellent agreement has been achieved between MR imaging and histology in identification of plaque components, such as intraplaque hemorrhage and lipid core. For assessing carotid plaque, MR imaging is superior to computed tomography and ultrasound imaging techniques due to its advantages including noninvasive imaging, lack of ionizing radiation, excellent soft tissue resolution, and multi-parametric image acquisition.
The Investigators hypothesize that there are specific characteristics in carotid vulnerable plaques in Chinese patients with ischemic cerebrovascular events such as ischemic stroke and transient ischemic attack (TIA). This study seeks to investigate the characteristics of vulnerable plaque in carotid arteries using high resolution, black-blood MR imaging in patients with recent TIA or ischemic stroke.
This is a cross-sectional, multicenter study. A total of 1000 patients will be recruited from more than 10 different hospitals across China within 3 years. All patients will undergo MR imaging for brain and carotid arteries within two weeks after symptom onset. The prevalence of carotid vulnerable plaque and its correlations with brain ischemic lesions, traditional risk factors, and regional distribution of China will be determined.
Conditions
- Ischemic Stroke
- Transient Ischemic Attack
- Carotid Atherosclerotic Disease
Sponsors & Collaborators
-
Tsinghua University
lead OTHER
Principal Investigators
-
Chun Yuan, PhD · Center for Biomedical Imaging Research, Department of Biomedical Engineering, Tsinghua University
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2014-06-30
- Completion
- 2014-12-31
Countries
- China
Study Locations
More Related Trials
-
Study on Vulnerable Plaque of Carotid Artery With Chinese Herbal and Insects Medicine
NCT03072225 ·Status: UNKNOWN ·Phase: PHASE2
-
Investigation of Multiple Ultrasound Techniques for the Assessment of Carotid Plaque Vulnerability
NCT04530721 ·Status: UNKNOWN
-
Establishment and Evaluation to the Effects of a Clinical Pathway for Acute Ischemic Stroke
NCT00966316 ·Status: COMPLETED ·Phase: PHASE4
-
Screening and Management of High-risk Populations of Stroke in Dehui City
NCT05039034 ·Status: COMPLETED
-
Xingnaojing for Mild-to-severe Acute Ischemic Stroke
NCT04150835 ·Status: UNKNOWN ·Phase: PHASE4
-
Artificial Intelligence Based Comprehensive Assessment System of Carotid Plaque Stability
NCT04544657 ·Status: UNKNOWN
-
The Screening of Neuroprotective Biomarkers After Acute Ischemic Stroke
NCT05689528 ·Status: COMPLETED
-
A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients
NCT05454397 ·Status: UNKNOWN
-
Molecular Characteristics of Phlegm-heat Syndrome in Ischemic Stroke
NCT06470477 ·Status: NOT_YET_RECRUITING
-
Different Treatment Strategies on Prognosis of Acute Ischemic Stroke(AISDTS)
NCT05410457 ·Status: RECRUITING
-
Evidence-based Evaluation of TCM Key Syndrome Differentiation and Treatment for Acute Ischemic Stroke
NCT04199455 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke
NCT00710164 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy of Butylphthalide on Symptomatic Atherosclerotic Stenosis in Middle Cerebral Artery
NCT06331494 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Development and Validation of the Prediction Model for Cognitive Impairment
NCT05465980 ·Status: UNKNOWN
-
Clinical Evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy
NCT03354026 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Reperfusion Therapy for Minor Ischemic Stroke in China
NCT07322835 ·Status: NOT_YET_RECRUITING
-
China Stroke Registry for Patients With Traditional Chinese Medicine
NCT04921397 ·Status: UNKNOWN
-
A Cohort Study on Cardiovascular and Cerebrovascular Outcomes
NCT07178015 ·Status: ENROLLING_BY_INVITATION
-
Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study
NCT07121088 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Dyslipidemia Management in Chinese Post Stroke Patients
NCT01897883 ·Status: COMPLETED
-
Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke
NCT04415164 ·Status: UNKNOWN ·Phase: PHASE4
-
A Clinical Trail of Integrative Medicine Approaches for Post-Stroke Cognitive Impairment
NCT04596072 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients
NCT00950521 ·Status: COMPLETED ·Phase: PHASE2
-
Jiedu Huayu Oral Prescription in the Treatment of Intracranial Hemorrhage Associated With Cerebral Amyloid Angiopathy
NCT07250035 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Intracerebral Transplantation of Neural Stem Cells for the Treatment of Ischemic Stroke
NCT03296618 ·Status: UNKNOWN ·Phase: PHASE1